Publication | Closed Access

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

OncologyPharmacologyBronchial NeoplasmImmune Checkpoint InhibitorFirst-line TreatmentCancer TreatmentMedicineLung Cancer